Search Drug Information, Interactions, Images, Dosage & Side Effects

Tumour immune barrier determines immunotherapy efficacy in HCC 01 Apr 2023
A tumour immune barrier (TIB) structure formed by the interaction of SPP1+ macrophages and cancer-associated fibroblasts (CAFs) appears to influence the efficacy of immunotherapy in patients with hepatocellular carcinoma (HCC), reveals a study.

STIs in women remain common despite doxycycline use after sex

01 Apr 2023

Secukinumab yields sustained positive effects on molecular, histopathologic psoriasis markers

01 Apr 2023

Long COVID: What are the risk and protective factors?

01 Apr 2023

Systemic antihypertensive medications exert diverse effects on glaucoma, IOP

31 Mar 2023

Certain ART combinations carry some risk of depression among women with HIV

31 Mar 2023

Oral HBV cccDNA inhibitor a promising cure against chronic HBV infection

31 Mar 2023

Long-term indapamide helps prevent death, cardiac events in at-risk patients

31 Mar 2023

Rituximab, cyclophosphamide deliver similar effects on ENT symptoms in AAV

31 Mar 2023

Novel device delivers improvements for BPH symptoms

31 Mar 2023

Antibiotics linked to higher EAC risk

31 Mar 2023

EMPULSE trial confirms the efficacy and safety profile of empagliflozin in patients stabilized in hospital following acute heart failure 21 Mar 2023;
Empagliflozin is the first SGLT-2i to significantly improve outcomes for patients with HF in any setting (in-hospital/outpatient), across the full spectrum of HF. Results from the EMPULSE trial showed that patients hospitalized for acute HF who were treated with empagliflozin following stabilization had 36% clinical benefit on the composite of mortality, HF events, and KCCQ-TSS improvement. The EMPULSE trial also provides a reassuring safety profile for empagliflozin that is consistent with previous trials.

Diagnosis & Management of Neuropathy in Primary Care Setting: ”Make It Simple”

03 Mar 2023

SARS-CoV-2 Variants: Everything you need to know

01 Feb 2023

Antimicrobial resistance: Next global, public health threat after COVID-19

Pank Jit Sin, 10 Jan 2023

Onoiwa/Onoiwa MX For Kids

Contents : Channa striata extr 5,100 mg, Moringa oleifera extr 240 mg, Curcuma xanthorrhiza extr 240 mg

Indications/Uses : Hypoalbuminemia, to increase albumin levels. Accelerate wound healing (DM, burns & post-op wounds). Malnutrition & nutritional support for pregnant women, childn & elderly patients. Improve edema; help in recovery process of critical illness, chronic disease & hospitalization. Improve the immune system & as an antioxidant; cell regeneration & complete nutrition after chemotherapy (cancer patients). COVID-19 adjuvant therapy. Childn w/ stunting & malnutrition.